Carrick Therapeutics
PrivateLast Round
Series D
Dec 1, 2022
Total Funding Raised
$190M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Carrick Therapeutics is a biotechnology company that develops innovative cancer therapeutics targeting molecular pathways to improve treatment outcomes for patients with aggressive and resistant forms of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Carrick Therapeutics Comparables
Compare Carrick Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Syros Pharmaceuticals Inc | 82% | |
| Avenzo Therapeutics | 79% | |
| Incyclix Bio | 79% |
Carrick Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Dec 1, 2022 | ||||
| Series B | Nov 14, 2019 | ||||
| Series A | Oct 3, 2016 |
Carrick Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EQT Life Sciences | Series B |
| SV Health Investors | Series A |
| GV | Series A, Series B, Series D |
| Lightstone Ventures | Series B, Series D, Series A |
| ARCH Venture Partners | Series D, Series A |
| Woodford Investment Management | Series B, Series A |
| ARCH Venture Partners | Series B, Series D, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 69% MoM, reaching 2.4K.
- Apr 20, 2026
Monthly visitors grew 249% MoM, reaching 2.5K.
Carrick Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Carrick Therapeutics's valuation, stock price, and market status.
Is Carrick Therapeutics a public or private company?
Carrick Therapeutics is a private company.
What is the current stock price of Carrick Therapeutics?
Carrick Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Carrick Therapeutics worth (valuation)?
Valuation information for Carrick Therapeutics is not publicly available.
Can I buy Carrick Therapeutics stock?
Carrick Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Carrick Therapeutics's last funding round?
Carrick Therapeutics's most recent funding round was Series D on December 1, 2022.
Who are the main investors in Carrick Therapeutics?
Key investors in Carrick Therapeutics include EQT Life Sciences, SV Health Investors, Woodford Investment Management, ARCH Venture Partners, Pfizer.
Will Carrick Therapeutics IPO soon?
No public IPO plans have been announced for Carrick Therapeutics.
How can I track Carrick Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Carrick Therapeutics's secondary market activity and sign up for updates.